Co-Authors
This is a "connection" page, showing publications co-authored by Eric Snijder and Adriaan de Wilde.
Connection Strength
4.083
-
Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology. 2018 09; 522:46-55.
Score: 0.776
-
Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture. Virology. 2018 04; 517:148-156.
Score: 0.746
-
Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model. Virus Res. 2017 01 15; 228:7-13.
Score: 0.692
-
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014 Aug; 58(8):4875-84.
Score: 0.582
-
A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. PLoS Biol. 2020 06; 18(6):e3000715.
Score: 0.222
-
Adaptive Mutations in Replicase Transmembrane Subunits Can Counteract Inhibition of Equine Arteritis Virus RNA Synthesis by Cyclophilin Inhibitors. J Virol. 2019 09 15; 93(18).
Score: 0.210
-
Host Factors in Coronavirus Replication. Curr Top Microbiol Immunol. 2018; 419:1-42.
Score: 0.187
-
A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins. J Virol. 2015 Aug; 89(16):8318-33.
Score: 0.156
-
MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-a treatment. J Gen Virol. 2013 Aug; 94(Pt 8):1749-1760.
Score: 0.135
-
Cyclosporin A inhibits the replication of diverse coronaviruses. J Gen Virol. 2011 Nov; 92(Pt 11):2542-2548.
Score: 0.119
-
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP. J Exp Med. 2021 07 05; 218(7).
Score: 0.060
-
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. NPJ Vaccines. 2020; 5:91.
Score: 0.057
-
a-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment. J Med Chem. 2020 05 14; 63(9):4562-4578.
Score: 0.054
-
Antiviral activity of K22 against members of the order Nidovirales. Virus Res. 2018 02 15; 246:28-34.
Score: 0.047
-
Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity. Bioorg Med Chem Lett. 2015 Aug 01; 25(15):2923-6.
Score: 0.039